Skip to main content
NVDA-0.29%AAPL+1.32%GOOGL-2.28%MSFT+0.02%AMZN+0.25%TSM-0.83%SPCX-3.86%AVGO-1.13%META+1.31%TSLA-0.52%SKHY+7.05%MU-1.17%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.45%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.60%0005.HK-0.78%HSBA.L-1.40%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.09%CHFJPY-1.57%AUDJPY-1.42%USDJPY-1.40%EURJPY-1.28%CADJPY-1.24%GBPJPY-1.21%GBPNZD+0.88%NZDCAD-0.86%EURNZD+0.85%NZDUSD-0.72%AUDNZD+0.70%NZDCHF-0.55%GBPTRY+0.41%USDNOK+0.41%EURNOK+0.35%GBPCHF+0.35%GBPHKD+0.32%CADCHF+0.31%EURCHF+0.29%GBPMXN-0.28%USDZAR+0.27%CHFNOK+0.27%SGDJPY+0.23%EURZAR+0.23%GBPZAR+0.23%PLNJPY+0.20%AUDCAD-0.19%USDTHB+0.19%AUDNOK+0.19%USDCHF+0.19%GBPUSD+0.18%GBPAUD+0.18%AUDCHF+0.16%AUDDKK-0.16%USDILS+0.16%USDSEK+0.16%USDPLN+0.14%USDCAD-0.14%EURAUD+0.14%NZDSGD+0.12%USDSGD+0.11%EURUSD+0.11%USDTRY+0.11%AUDSGD-0.11%EURSEK+0.10%USDMXN+0.10%NZDMXN+0.09%EURCZK-0.08%EURPLN+0.08%NOKJPY-0.07%EURHKD-0.07%USDDKK+0.06%GBPSGD+0.06%EURSGD+0.06%EURCNH-0.05%EURGBP-0.05%USDCOP-0.04%EURCAD-0.04%CHFSEK+0.03%CHFSGD-0.02%AUDUSD-0.02%GBPCAD+0.02%USDCNH-0.01%USDHKD+0.01%EURDKK0.00%HG1-3.95%COFFEE-2.41%XPTUSD-2.35%GAGUSD-1.89%XAGUSD-1.88%SUGAR+1.64%COCOA-1.36%COTTON+1.07%C1+0.52%S1+0.47%XAUUSD-0.42%GAUUSD-0.42%BTCUSD-0.42%ETHUSD+0.02%USDTUSD-0.08%XRPUSD-1.30%SOLUSD-0.31%TRXUSDT+0.48%ZECUSDT-1.46%DOGEUSD-1.02%XMRUSDT-0.97%LINKUSD-0.08%XLMUSD-0.92%BCHUSDT-2.37%LTCUSD-1.50%UNIUSD-2.16%TONUSD+24.88%HBARUSDT-1.15%SUIUSD-1.36%TAOUSDT-0.98%AAVEUSD-1.96%DOTUSDT-2.27%ICPUSDT-0.94%ONDOUSDT-1.87%WLDUSDT-1.47%ATOMUSDT-2.81%ARBUSDT-0.87%JUPUSDT-2.10%INJUSDT-1.87%STXUSDT-3.07%FETUSDT-2.86%TIAUSDT-0.60%SEIUSDT-1.80%PYTHUSDT-0.97%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.49%OPUSDT-1.99%IOTAUSDT-2.57%POLUSDT-5.47%AXSUSDT-1.50%FARTCOINUSDT-1.63%EOSUSDT+0.18%DYDXUSDT+0.26%ORDIUSDT+0.35%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.29%AAPL+1.32%GOOGL-2.28%MSFT+0.02%AMZN+0.25%TSM-0.83%SPCX-3.86%AVGO-1.13%META+1.31%TSLA-0.52%SKHY+7.05%MU-1.17%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.45%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.60%0005.HK-0.78%HSBA.L-1.40%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.09%CHFJPY-1.57%AUDJPY-1.42%USDJPY-1.40%EURJPY-1.28%CADJPY-1.24%GBPJPY-1.21%GBPNZD+0.88%NZDCAD-0.86%EURNZD+0.85%NZDUSD-0.72%AUDNZD+0.70%NZDCHF-0.55%GBPTRY+0.41%USDNOK+0.41%EURNOK+0.35%GBPCHF+0.35%GBPHKD+0.32%CADCHF+0.31%EURCHF+0.29%GBPMXN-0.28%USDZAR+0.27%CHFNOK+0.27%SGDJPY+0.23%EURZAR+0.23%GBPZAR+0.23%PLNJPY+0.20%AUDCAD-0.19%USDTHB+0.19%AUDNOK+0.19%USDCHF+0.19%GBPUSD+0.18%GBPAUD+0.18%AUDCHF+0.16%AUDDKK-0.16%USDILS+0.16%USDSEK+0.16%USDPLN+0.14%USDCAD-0.14%EURAUD+0.14%NZDSGD+0.12%USDSGD+0.11%EURUSD+0.11%USDTRY+0.11%AUDSGD-0.11%EURSEK+0.10%USDMXN+0.10%NZDMXN+0.09%EURCZK-0.08%EURPLN+0.08%NOKJPY-0.07%EURHKD-0.07%USDDKK+0.06%GBPSGD+0.06%EURSGD+0.06%EURCNH-0.05%EURGBP-0.05%USDCOP-0.04%EURCAD-0.04%CHFSEK+0.03%CHFSGD-0.02%AUDUSD-0.02%GBPCAD+0.02%USDCNH-0.01%USDHKD+0.01%EURDKK0.00%HG1-3.95%COFFEE-2.41%XPTUSD-2.35%GAGUSD-1.89%XAGUSD-1.88%SUGAR+1.64%COCOA-1.36%COTTON+1.07%C1+0.52%S1+0.47%XAUUSD-0.42%GAUUSD-0.42%BTCUSD-0.42%ETHUSD+0.02%USDTUSD-0.08%XRPUSD-1.30%SOLUSD-0.31%TRXUSDT+0.48%ZECUSDT-1.46%DOGEUSD-1.02%XMRUSDT-0.97%LINKUSD-0.08%XLMUSD-0.92%BCHUSDT-2.37%LTCUSD-1.50%UNIUSD-2.16%TONUSD+24.88%HBARUSDT-1.15%SUIUSD-1.36%TAOUSDT-0.98%AAVEUSD-1.96%DOTUSDT-2.27%ICPUSDT-0.94%ONDOUSDT-1.87%WLDUSDT-1.47%ATOMUSDT-2.81%ARBUSDT-0.87%JUPUSDT-2.10%INJUSDT-1.87%STXUSDT-3.07%FETUSDT-2.86%TIAUSDT-0.60%SEIUSDT-1.80%PYTHUSDT-0.97%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.49%OPUSDT-1.99%IOTAUSDT-2.57%POLUSDT-5.47%AXSUSDT-1.50%FARTCOINUSDT-1.63%EOSUSDT+0.18%DYDXUSDT+0.26%ORDIUSDT+0.35%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%
HH

Harrow Health, Inc. (HROW)

NASDAQ • Healthcare

$37.54
-$0.3 (-0.8%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$37.92
Day Range$37.4 - $38
Avg. Volume (3M)486.7K
Market Cap$1.3B
52 Week Range
$28.54$54.85
Next EarningsIn 60 daysNov 9, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$70.6M100%
Gross Profitminus cost of goods$50.3M71%

In plain terms: out of every $100 in revenue, Harrow Health, Inc. currently loses $24.

Fundamentals & Financials

Revenue (TTM)
$275.5M
Net Income (TTM)
-$37.2M
EPS (TTM)
-$0.99
ROA (TTM)
-8.93%
Current Ratio
2.24
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-55.0%Q1 2026$0.18
-72.1%Q2 2026-$0.74
-157.3%Q3 2026-$0.46
Next

Nov 9

in 60 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Harrow Health, Inc.

Harrow Health, Inc. (NASDAQ: HROW) is a healthcare company that develops and sells specialty ophthalmic pharmaceuticals and compounded medicines. Through its ImprimisRx brand and products such as DEXYCU, it serves eye-care needs including post-operative inflammation management, and it generated $272.3 million in FY2025 revenue.

Name
Harrow Health, Inc.
CEO
Mark L. Baum
Website
www.harrow.com
Industry
Healthcare
Year Founded
2006
Employees
373

Today's Snapshot

AI-generated

The day ended with HROW 0.8% lower at 37.55, while its sector was flat. Leerink, a brokerage, began covering Harrow, expecting its shares to beat the market.

Trading Volume

Below 10d avg (419.7K)

354.6K

vs S&P 500 Today

Moderate Underperformance

-0.37%

Updated: September 9, 2026 at 20:28 UTC

Technical Indicators

0 Buy2 Neutral6 Sell
HROW exhibits clear short-to-medium-term weakness as the price sits below the 10–200 day averages and momentum indicators are biased downward, with MACD negative and Momentum showing meaningful decline. Trend strength is muted with ADX around the mid‑teens and volatility moderate by ATR, while volume metrics point to distribution. Oscillators are not deeply oversold, leaving limited evidence of an imminent reversal, and the pivot level is essentially at current price. Technical takeaway: Strong Sell — short/medium-term moving averages and negative momentum dominate in a low‑strength trend.
All signals
  • EMA (5 indicators)$38.31 - $40.95
    Sell
  • RSI (14)42.76
    Neutral
  • Stochastic %K (14, 3, 3)26.78
    Neutral
  • MACD Level (12, 26)-0.69
    Sell

Peers & Related Assets

TRVITrevi Therapeutics, Inc.
$16.64-1.1%
BLFSBioLife Solutions, Inc.
$34.93-1.3%
KMTSKestra Medical Technologies, Ltd.
$24.07-6.1%
AMPHAmphastar Pharmaceuticals, Inc.
$23.04+0.5%
COLLCollegium Pharmaceutical, Inc.
$23.36-0.0%
PHRPhreesia, Inc.
$10.34+1.2%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.